| BIOCRYST PHARMACEUTICALS |
| USA |
| Gesundheit |
| US09058V1035 / 896047 |
| BO1 (Frankfurt) / BCRX (NASDAQ) |
| FRA:BO1, ETR:BO1, BO1:GR, NASDAQ:BCRX |
| - |
| https://www.biocryst.com/ |
|
BioCryst Pharmaceuticals Inc. is a biotechnology c..
>Volltext.. |
| 1310.58 Mio. EUR |
| 1711.13 Mio. EUR |
| 512.17 Mio. EUR |
| 66.09 Mio. EUR |
| -7.5 Mio. EUR |
| -0.04 EUR |
| 583.29 Mio. EUR |
| 72.29 Mio. EUR |
| 42.68 Mio. EUR |
| 1.12 |
| 37.94% |
| 93.27% |
| - |
| - |
| - |
| BIOCRYST |
| 20.12.25 |
|